Viewing Study NCT04809220


Ignite Creation Date: 2025-12-25 @ 4:13 AM
Ignite Modification Date: 2025-12-26 @ 3:12 AM
Study NCT ID: NCT04809220
Status: COMPLETED
Last Update Posted: 2024-05-22
First Post: 2021-03-19
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: A Study of Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type 2 Diabetes
Sponsor: Eli Lilly and Company
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 17779
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators